OSAM
KYMR icon

O'Shaughnessy Asset Management’s Kymera Therapeutics KYMR Stock Holding History

O'Shaughnessy Asset Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+1,941
New +$167K ﹤0.01% 1987
2021
Q4 		– Sell
-1,087
Closed -$64K – 1897
2021
Q3 		$64K Buy
+1,087
New +$63K ﹤0.01% 1549

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

O'Shaughnessy Asset Management's KYMR Position: Q2 2026 in Review

O'Shaughnessy Asset Management opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 1,941 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #1987 among its holdings. This is a return to the name: O'Shaughnessy Asset Management previously reported a position in KYMR as recently as Q3 2021.

O'Shaughnessy Asset Management first reported a position in KYMR in Q3 2021 and has held it in 2 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • O'Shaughnessy Asset Management held 1,941 shares of Kymera Therapeutics worth $223K as of Q2 2026.
  • Kymera Therapeutics was a new O'Shaughnessy Asset Management position in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1987 holding.
  • O'Shaughnessy Asset Management first reported a position in Kymera Therapeutics in Q3 2021 and has held it in 2 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.